Statin set to become next big POM-to-P switch:is this good news for patients?

The Pharmaceutical Journal Group

首页> 外文期刊>The pharmaceutical journal >Statin set to become next big POM-to-P switch:is this good news for patients?

【24h】

Statin set to become next big POM-to-P switch:is this good news for patients?

机译：Statin将成为下一个POM到P的大开关：这对患者来说是个好消息吗？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The Government bas announced the launcd of a two-month consultation on the reclassification of simvastatin from prescription only to pbarmacy medicine.Harriet Adcock examines some initial responses.

机译：政府宣布将进行为期两个月的磋商，以期将辛伐他汀从处方药重新分类为抗肿瘤药。HarrietAdcock研究了一些初步反应。

著录项

来源
《The pharmaceutical journal》 |2003年第7276期|共1页
作者
The Pharmaceutical Journal Group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Statin set to become next big POM-to-P switch:is this good news for patients? [J] . The Pharmaceutical Journal Group The pharmaceutical journal . 2003,第7276期

机译：Statin将成为下一个POM到P的大开关：这对患者来说是个好消息吗？
2. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education [J] . WeiM.Y., ItoM.K., CohenJ.D., Journal of clinical lipidology . 2013,第5期

机译：他汀类药物在USAGE调查中的依从性，转换和停用情况的预测因素：了解在美国使用他汀类药物和患者教育方面的差距
3. Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study [J] . ParkY., JeongY.-H., TantryU.S., European Heart Journal: The Journal of the European Society of Cardiology . 2012,第17期

机译：在高血小板反应性患者中通过将阿托伐他汀转换为非CYP3A4代谢的他汀来加速血小板抑制（ACCEL-STATIN）研究
4. Liver Enzymes as Biomarkers for Hepatotoxicity of Statins in Patients with Dyslipidemia [C] . N. Velickova, M. Nateva, S. Stojanovska International Conference on Medical and Biological Engineering . 2020

机译：肝酶作为血脂血症患者肝毒性的生物标志物
5. Physician and patient influences in statin treatment adherence and associated outcomes in V.A. patients with hypercholesterolemia. [D] . Campione, Joanne Rita. 2005

机译：医师和患者对他汀类药物治疗依从性及相关结果的影响高胆固醇血症患者。
6. Switching from EPA + DHA (Omega-3-acid Ethyl Esters) to High-Purity EPA (Icosapent Ethyl) in a Statin-Treated Patient with Persistent Dyslipidemia and High Cardiovascular Risk: A Case Study [O] . James R. Crandell 2016

机译：一名患有持久血脂异常和高心血管风险的患者中从EPA + DHA（Omega-3-酸乙基酯）转换为高纯度EPA（二十碳五乙基酯）的案例研究
7. TCT-163: Accelerated Platelet Inhibition after Switching with Hydrophilic Statin in Patients with Increased Platelet Reactivity During Atorvastatin and Clopidogrel Coadministration (ACCEL-STATIN) study: a randomized, parallel-group trial [O] . 2011

机译：TCT-163：在阿托伐他汀和氯吡格雷共同给药（ACCEL-STATIN）研究期间血小板反应性增加的患者中，使用亲水性他汀类药物转换后加速的血小板抑制作用：一项随机平行试验

Statin set to become next big POM-to-P switch:is this good news for patients?

摘要

著录项

相似文献

相关主题

期刊订阅